Furthermore, anti-complement component C5 therapy is very effective in improving rapidly progressive multiple arterial thrombosis resistant to anticoagulants and antiplatelet agents due to PNH. The gene discussed is C5; the disease is paroxysmal nocturnal hemoglobinuria.